Soligenix amends loan deal with Pontifax; conversion price cut to $3.81/$4.23

SOLIGENIX, INC.

Conversion price reduced to $3.81 for first 501,648 shares issued after Oct 7, 2024, then $4.23 for subsequent shares.
Amendment allows Soligenix to satisfy remaining loan balance with stock instead of cash, extending cash runway.
Lenders agreed to lock-up in future offerings and capped aggregate stock ownership at 19.99% of outstanding shares.
All other terms of the December 2020 Loan and Security Agreement remain unchanged; effective October 8, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.